Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05863754 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Grasp-Release Assessment of a Networked Neuroprosthesis Device

Study acronym: GRANND
StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

  1. Site contact updatedv5
  2. Primary completion date: Dec 1, 2026 to Dec 1, 2027
    • Study completion date: Dec 1, 2027 to Dec 1, 2028
    • Site contact updated
    v4
  3. Primary completion date: Apr 1, 2026 to Dec 1, 2026
    • Study completion date: Apr 1, 2027 to Dec 1, 2027
    • Start date: Feb 23, 2022 to Jan 23, 2022
    v3
  4. Primary completion date: Dec 31, 2026 to Apr 1, 2026
    • Study completion date: Dec 31, 2027 to Apr 1, 2027
    v2
  5. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The overall objective of this trial is to characterize the safety and effectiveness of the Networked Neuroprosthesis Device - Upper Extremity (NP-UE) in individuals living with cervical SCI.
Trial Details
NCT Number NCT05863754
Lead Sponsor MetroHealth Medical Center
Collaborators: National Institute of Neurological Disorders and Stroke (NINDS), Case Western Reserve University
Conditions
(from sponsor)		 Spinal Cord Injury at C5-C7 Level, Spinal Cord Injuries, Spinal Cord Injury Cervical
Related terms Spinal Cord Injuries
Enrollment 13 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov